Ongoing proof-of-concept (PoC) clinical trial in pain associated with pancreatic cancer with topline data on track for 1H ...
NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) Q1 2025 Earnings Call Transcript February 12, 2025 NeuroOne Medical Technologies Corporation beats earnings expectations. Reported EPS is ...
Dave Rosa; President, Chief Executive Officer, Director; Neuroone Medical Technologies Corp. Ron McClurg; Chief Financial Officer; Neuroone Medical Technologies Corp ...
A revolutionary new treatment called Targeted Thermal Therapy (Triple T) has shown promise as a safer, faster alternative to surgery ...
Doctors at Queen Mary University of London, Barts Health NHS Trust, and University College London have led the development of ...
Request To Download Free Sample of This Strategic Report @ Highlighted with 22 tables and 34 figures, this 83-page report Europe Endometrial Ablation Market 2022-2032 by Offering (Devices, Procedures ...
Request To Download Free Sample of This Strategic Report @ Highlighted with 81 tables and 70 figures, this 145-page report Global Endometrial Ablation Market 2022-2032 by Offering (Devices, ...
By now, many have seen the commercials with NBA legend Kareem Abdul-Jabbar explaining the importance of seeing ...
NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) Q1 2025Management ViewCEO Dave Rosa highlighted the strong performance ...
Total revenue of $6.3M Includes $3.3 Million of Product Revenue in Addition to a One-Time Upfront Payment of $3.0 Million in License Revenu ...
Reports Q1 product revenue $3.3M vs. $1M last year. Reports Q1 license revenue $3M vs. $0 last year. “This quarter marks the next step forward ...